These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 17462000

  • 21. Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma.
    Bachanova V, Brunstein CG, Burns LJ, Miller JS, Luo X, Defor T, Young JA, Weisdorf DJ, Tomblyn M.
    Bone Marrow Transplant; 2009 Feb; 43(3):237-44. PubMed ID: 18806838
    [Abstract] [Full Text] [Related]

  • 22. Nonhemolytic passenger lymphocyte syndrome with anti-Jk after allogeneic peripheral blood progenitor cell transplantation.
    Leo A, Lenz V, Winteroll S.
    Transfusion; 2004 Aug; 44(8):1259-60. PubMed ID: 15265136
    [No Abstract] [Full Text] [Related]

  • 23. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
    Bartsch K, Al-Ali H, Reinhardt A, Franke C, Hudecek M, Kamprad M, Tschiedel S, Cross M, Niederwieser D, Gentilini C.
    Transplantation; 2009 Jan 27; 87(2):217-21. PubMed ID: 19155975
    [Abstract] [Full Text] [Related]

  • 24. Sustained telomere erosion due to increased stem cell turnover during triple autologous hematopoietic stem cell transplantation.
    Widmann T, Kneer H, König J, Herrmann M, Pfreundschuh M.
    Exp Hematol; 2008 Jan 27; 36(1):104-10. PubMed ID: 17949890
    [Abstract] [Full Text] [Related]

  • 25. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
    Meisel R, Laws HJ, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Schmitz M, Fischer J, Göbel U, Enczmann J, Dilloo D.
    Biol Blood Marrow Transplant; 2007 Nov 27; 13(11):1338-45. PubMed ID: 17950920
    [Abstract] [Full Text] [Related]

  • 26. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
    You Y, Li QB, Chen ZC, Li WM, Xia LH, Zhou H, Zou P.
    Chin Med J (Engl); 2008 Sep 20; 121(18):1770-4. PubMed ID: 19080355
    [Abstract] [Full Text] [Related]

  • 27. Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
    Sureda A, Robinson S, Canals C, Carella AM, Boogaerts MA, Caballero D, Hunter AE, Kanz L, Slavin S, Cornelissen JJ, Gramatzki M, Niederwieser D, Russell NH, Schmitz N.
    J Clin Oncol; 2008 Jan 20; 26(3):455-62. PubMed ID: 18086796
    [Abstract] [Full Text] [Related]

  • 28. Durable remission of large B-cell lymphoma transformed from lymphoplasmacytic lymphoma/Waldenström macroglobulinemia successfully treated with sequential immunochemotherapy followed by reduced-intensity allogeneic stem cell transplantation.
    Yamamoto R, Takaori-Kondo A, Kanda J, Imada K, Ichinohe T, Ishikawa T, Ohmori K, Uchiyama T.
    Bone Marrow Transplant; 2008 Mar 20; 41(6):591-3. PubMed ID: 18071292
    [No Abstract] [Full Text] [Related]

  • 29. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
    Kuruvilla J, Shepherd JD, Sutherland HJ, Nevill TJ, Nitta J, Le A, Forrest DL, Hogge DE, Lavoie JC, Nantel SH, Toze CL, Smith CA, Barnett MJ, Song KW.
    Biol Blood Marrow Transplant; 2007 Aug 20; 13(8):925-31. PubMed ID: 17640596
    [Abstract] [Full Text] [Related]

  • 30. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F, Lang PJ, Ottinger H, Faul C, Bethge W, Handgretinger R, Bamberg M, Belka C.
    Int J Radiat Oncol Biol Phys; 2008 Feb 01; 70(2):523-8. PubMed ID: 17869449
    [Abstract] [Full Text] [Related]

  • 31. A case report of thrombotic thrombocytopenic purpura and severe acute renal failure post non-myeloablative allogeneic peripheral blood stem cell transplantation treated with plasma exchange and hemodialysis.
    Kida Y, Ishii T, Ando M, Kanda E, Suzuki H, Kida A, Yamashita T, Sakamaki H, Saito H.
    Ther Apher Dial; 2007 Oct 01; 11(5):402-6. PubMed ID: 17845402
    [Abstract] [Full Text] [Related]

  • 32. Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation.
    Wirk B, Klumpp TR, Ulicny J, Herman JH, Gajewski JL, Martin ME, Emmons RV, Mangan KF.
    Transfusion; 2008 Jan 01; 48(1):163-8. PubMed ID: 17900280
    [Abstract] [Full Text] [Related]

  • 33. Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
    Kako S, Izutsu K, Oshima K, Sato H, Kanda Y, Motokura T, Chiba S, Kurokawa M.
    Am J Hematol; 2007 Oct 01; 82(10):937-9. PubMed ID: 17663389
    [Abstract] [Full Text] [Related]

  • 34. The first 2 years of clinical experience with peripheral blood stem cell transplantation for various hematological malignancies: results from a single Baskent University Center.
    Ozdogu H, Boga C, Kizilkilic E, Kozanoglu I, Karakus S, Sahin FI, Unalan D, Haberal M.
    Transplant Proc; 2007 May 01; 39(4):1257-60. PubMed ID: 17524948
    [Abstract] [Full Text] [Related]

  • 35. The role of pegfilgrastim in mobilization of hematopoietic stem cells.
    Kroschinsky F, Hölig K, Ehninger G.
    Transfus Apher Sci; 2008 Jun 01; 38(3):237-44. PubMed ID: 18490197
    [Abstract] [Full Text] [Related]

  • 36. [The molecular characteristics of T-cell immune reconstitution in leukemia patients after allogeneic hematopoietic stem cell transplantation].
    Fu YW, Wu DP, Sun AN, Feng YF, Chang WR, Zhu ZL, Zhu P.
    Zhonghua Xue Ye Xue Za Zhi; 2007 May 01; 28(5):312-7. PubMed ID: 17877159
    [Abstract] [Full Text] [Related]

  • 37. Nephrotic syndrome in a patient with relapsed of chronic myeloid leukemia after peripheral blood stem cell transplantation.
    Bee PC, Gan GG, Sangkar VJ, Haris AR.
    Med J Malaysia; 2008 Mar 01; 63(1):71-2. PubMed ID: 18935742
    [Abstract] [Full Text] [Related]

  • 38. A case of acute cutaneous graft-versus-host disease mimicking psoriasis vulgaris.
    Matsushita T, Hasegawa M, Shirasaki F, Fujimoto M, Yamazaki H, Sato S, Takehara K.
    Dermatology; 2008 Mar 01; 216(1):64-7. PubMed ID: 18032902
    [Abstract] [Full Text] [Related]

  • 39. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
    Ghavamzadeh A, Iravani M, Ashouri A, Mousavi SA, Mahdavi N, Shamshiri A, Hadjibabaie M, Namdar R, Nedaeifard L, Ghaffari H, Alimoghaddam K.
    Biol Blood Marrow Transplant; 2008 Mar 01; 14(3):301-8. PubMed ID: 18275896
    [Abstract] [Full Text] [Related]

  • 40. [Treatment of stage IV neuroblastoma with allogeneic hematopoietic stem cell transplantation in children].
    Lu QY, Wang Z, Li P, Niu XQ, Zhang P, Zhao JN.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug 01; 10(4):464-6. PubMed ID: 18706162
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.